High expression of PD-1 ligands is associated with kataegis mutational signature and APOBEC3 alterations.
about
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers.Hypermutated Circulating Tumor DNA: Correlation with Response to Checkpoint Inhibitor-Based Immunotherapy.APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolution.Viral subversion of APOBEC3s: Lessons for anti-tumor immunity and tumor immunotherapy.APOBEC3B and APOBEC mutational signature as potential predictive markers for immunotherapy response in non-small cell lung cancer.DNA repair defects and implications for immunotherapyActivation of viral defense signaling in cancerBiomarkers for predicting efficacy of PD-1/PD-L1 inhibitors
P2860
Q38611235-7D203468-3CD8-401D-B637-D5B48B2133F4Q46685856-B585FAE7-BA5D-4F0B-A0CE-E217AC1892B8Q47555165-E0853AEA-0F1D-4F9B-80CE-24E047610580Q47568875-68A5D6EB-8074-4A22-A260-CC9B076FE805Q52562762-687F92E1-756A-45C6-8F73-D947F46F7CEBQ57057014-D9F85E4A-BD10-4E8C-A666-EAD132EFABE4Q58695217-DB571AE3-61A8-4253-86BD-AAA54596627AQ58713932-EA37C27E-2110-4730-BA12-93029F1285E5
P2860
High expression of PD-1 ligands is associated with kataegis mutational signature and APOBEC3 alterations.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
High expression of PD-1 ligand ...... ature and APOBEC3 alterations.
@en
type
label
High expression of PD-1 ligand ...... ature and APOBEC3 alterations.
@en
prefLabel
High expression of PD-1 ligand ...... ature and APOBEC3 alterations.
@en
P2860
P1433
P1476
High expression of PD-1 ligand ...... ature and APOBEC3 alterations.
@en
P2093
Amélie Boichard
Igor F Tsigelny
P2860
P304
P356
10.1080/2162402X.2017.1284719
P577
2017-01-31T00:00:00Z